Dan Arnold: Stelmach’s Perplexing Departure A Fitting End To Baffling Career

Goal : In the mid-1980s, interest in parenteral estrogen therapy for prostate cancer was renewed when it was found that it influenced liver metabolism solely marginally and had very few cardiovascular aspect-effects. In this examine excessive-dose polyestradiol phosphate (PEP; Estradurin ® ) was compared to combined androgen deprivation (CAD) for the therapy of patients with …

Dan Arnold: Stelmach’s Perplexing Departure A Fitting End To Baffling Career Read More »